Chongqing Zhifei Biological Products Co., Ltd.
300122
Rank in Stocks
#3778
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Share Price
$1.85
Market Cap
$4.42B
Change (1 day)
1.92%
Change (1 year)
-35.07%
Country
CN
Trade Chongqing Zhifei Biological Products Co., Ltd. (300122)
Category
Healthcare
Number of shares outstanding for Chongqing Zhifei Biological Products Co., Ltd. (300122)
Number of shares outstanding as of June 2026: 2.39B
According to Chongqing Zhifei Biological Products Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 2.39B. At the end of December 2023 the company had 2.40B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Chongqing Zhifei Biological Products Co., Ltd. (300122) from 2007 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 2.39B | -0.06% |
| 2024 | 2.40B | -0.20% |
| 2023 | 2.40B | 0.00% |
| 2022 | 2.40B | 50.00% |
| 2021 | 1.60B | 0.00% |
| 2020 | 1.60B | 0.00% |
| 2019 | 1.60B | -0.01% |
| 2018 | 1.60B | 0.00% |
| 2017 | 1.60B | 2.99% |
| 2016 | 1.55B | -2.53% |
| 2015 | 1.59B | -1.36% |
| 2014 | 1.62B | 0.29% |
| 2013 | 1.61B | 0.19% |
| 2012 | 1.61B | 1.56% |
| 2011 | 1.58B | 13.16% |
| 2010 | 1.40B | -37.22% |
| 2009 | 2.23B | 0.91% |
| 2008 | 2.21B | -0.92% |
| 2007 | 2.23B | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -89.39% |
US
|
|
| 396.00M | -83.46% |
US
|
|
| 478.91M | -79.99% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -97.40% |
NL
|
